Ferna´ndez et al.
mmol), Pd(PPh3)2Cl2 (50 mg, 0.07 mmol), and CuI (6.8 mg, 0.035
mmol) were added. The resulting solution was stirred overnight at
room temperature. The solvent was evaporated to dryness, and the
crude product was purified by column chromatography [SiO2,
chloroform/methanol (20:1)] to afford 5a (120 mg, 32%) as an
orange solid. 1H NMR (CDCl3, 300 MHz) δ 9.92 (s, 2H), 9.90 (s,
2H), 7.74 (dd, J ) 8.4 Hz, 8H), 7.72 (dd, J ) 3.9 Hz, 4H), 7.39
(dd, J ) 3.9 Hz, 4H), 7.28 (s, 2H), 7.05 (s, 2H), 4.06 (t, J ) 6.4
Hz, 4H), 1.92-1.83 (m, 4H), 1.65-1.52 (m, 4H), 1.43-1.26 (m,
8H), 0.89 (t, J ) 6.8 Hz, 6H). 13C NMR (DMSO-d6, 75 MHz) δ
185.1, 154.1, 144.3, 139.8, 138.9, 138.6, 137.5, 137.0, 135.5, 134.9,
134.8, 134.7, 132.9, 132.4, 132.3, 131.4, 131.3, 130.9, 130.3, 129.1,
128.7, 80.2, 80.0, 79.8, 61.5, 55.7, 32.1, 29.8, 29.5, 26.3, 26.1, 22.9,
14.8. FTIR (KBr) ν 2922, 2852, 2200, 1662, 1598, 1456, 1217,
777, 756, 669 cm-1. UV-vis (CHCl3) λmax (ꢀ) 360 (83 400), 443
(88 500) nm. ESI-MS m/z: 1066.2 [M + H+].
145.15, 145.12, 145.07, 145.02, 144.9, 144.6, 144.55, 144.52, 144.3,
144.2, 144.14, 144.10, 143.9, 143.8, 143.4, 143.0,142.8, 142.5,
142.43, 142.40, 142.2, 142.1, 142.0, 141.98, 141.92, 141.88, 141.83,
141.7, 141.6, 141.9, 141.4, 140.0, 139.8, 139.6, 137.0, 136.4, 135.7,
135.3, 135.0, 132.1, 131.8, 131.7, 131.4, 128.79, 128.73, 127.9,
127.8, 127.77, 127.70, 124.3, 124.2, 123.9, 123.7, 116.5, 78.0, 69.3,
69.2, 68.3, 66.8, 32.05, 32.01, 31.6, 29.7, 29.48, 29.40, 28.4, 27.6,
25.8, 22.91, 22.88, 22.83, 14.3, 14.1. FTIR (KBr) ν 2920, 2850,
2187, 1596, 1463, 1210, 758, 526 cm-1. UV-vis (CHCl3) λmax (ꢀ)
322 (147 000), 426 (60 000) nm. MALDI-TOF MS m/z: 4446.4
[M+].
Compound 7. A solution of 5b (170 mg, 0.16 mmol), N-
octylglycine (172 mg, 0.95 mmol), and C60 (914 mg, 1.27 mmol)
in chlorobenzene (50 mL) was heated under reflux overnight. The
solvent was evaporated to dryness, and the crude product was
purified by column chromatography [SiO2, CS2, chloroform] to
afford 7 (150 mg, 21%) as a black solid. 1H NMR (D2O, 300 MHz)
δ 7.92 (br d, 4H), 7.54-7.05 (m, 20H, Ar), 5.45 (br s, 4H), 5.18
(br s, 4H), 4.22 (br s, 4H), 4.10 (br t, 4H), 3.54-3.08 (m, 34H),
2.73-0.99 (m, 60H). 13C NMR (D2O, 75 MHz) δ 156.2, 155.5,
154.3, 154.2, 153.39, 153.32, 153.27, 153.22, 153.1, 151.6, 147.8,
147.29, 147.25, 146.94, 146.91, 146.84, 146.80, 146.78, 146.73,
146.65, 146.62, 146.5, 146.4, 146.3, 146.28, 146.23, 146.1, 146.04,
146.02, 146.00, 145.84, 145.80, 145.7, 145.3, 145.27, 145.24, 145.1,
144.9, 144.1, 143.7, 143.6, 143.5, 143.4, 143.3, 143.1, 142.8, 142.7,
142.6, 142.5, 142.4, 142.3, 142.25, 142.22, 140.8, 140.6, 140.45,
140.43, 137.7, 137.29, 137.2, 136.9, 136.4, 136.1, 135.2, 132.7,
132.2, 131.8, 130.2, 128.7, 128.5, 128.3, 127.4, 127.2, 125.4, 125.2,
124.8, 110.6, 102.7, 97.1, 95.2, 94.2, 92.9, 89.8, 89.2, 83.8, 78.9,
77.7, 77.2, 77.0, 76.9, 71.1, 69.6, 69.0, 68.5, 67.6, 55.7, 54.4, 33.1,
33.0, 32.7, 30.8, 30.5, 29.5, 28.6, 27.1, 24.1, 24.0, 15.4, 15.3. FTIR
(KBr) ν 2920, 2850, 2180, 1595, 1463, 1178, 1114, 810, 769, 758,
526 cm-1. UV-vis (CHCl3) λmax (ꢀ) 255 (257 000), 325 (92 500),
467 (40 000) nm. MALDI-TOF MS m/z: 4450.6 [M+].
Compound 5b. To a solution of 3b (430 mg, 0.467 mmol) and
5-bromothiophene-2-carboxaldehyde (0.55 mL, 4.64 mmol) in Et3N/
MeOH (3:1) (40 mL) under Ar atmosphere, KF (217 mg, 3.74
mmol), Pd(PPh3)2Cl2 (65 mg, 0.093 mmol), and CuI (9 mg, 0.047
mmol) were added. The resulting solution was stirred overnight at
room temperature. The solvent was evaporated to dryness, and the
crude product was purified by column chromatography [SiO2,
1
chloroform] to afford 5b (270 mg, 54%) as a dark-red solid. H
NMR (CDCl3, 300 MHz) δ 9.92 (s, 2H), 9.89 (s, 2H), 7.90 (d, J )
8.4 Hz, 4H), 7.72 (dd, J ) 3.9 Hz, 4H), 7.61-7.57 (m, 6H), 7.39
(dd, J ) 3.8 Hz, 4H), 7.29 (s, 2H), 7.22 (s, 1H), 7.17-7.15 (m,
3H), 4.10 (t, J ) 6.4 Hz, 4H), 1.91 (m, 4H), 1.57 (m, 4H), 1.41
(m, 8H), 0.93 (br t, J ) 6.9 Hz, 6H). 13C NMR (CDCl3, 75 MHz)
δ 183.0, 182.8, 151.7, 146.4, 145.2, 144.6, 144.2, 140.5, 137.4,
136.4, 134.9, 134.8, 134.7, 134.4, 133.5, 133.3, 132.6, 132.1, 131.4,
130.7, 130.3, 128.8, 128.7, 128.6, 128.5, 128.4, 127.3, 127.1, 126.9,
125.8, 111.06, 100.8, 97.0, 94.9, 88.3, 82.3, 69.9, 32.0, 30.1, 29.8,
26.3, 23.0, 14.4. FTIR (KBr) ν 3053, 3022, 2925, 2854, 2194, 1668,
1595, 1425, 1220, 1197, 808, 721, 694, 669, 578, 542 cm-1. UV-
vis (CHCl3) λmax (ꢀ) 336 (94 600), 492 (110 000) nm. ESI-MS
m/z: 1070.3 [M + H+].
Acknowledgment. Financial support from the MCyT of
Spain and Comunidad de Madrid (Projects BQU2002-00855
and P-PPQ-000225-0505), the EU (RTN network “WONDER-
FULL” and “CASSIUS CLAYS”, and NAIMO Integrated
Project NMP4-CT-2004-500355), SFB 583, DFG(GU 517/4-
1), FCI, and the Office of Basic Energy Sciences of the U.S.
Department of Energy (NDRL-5000) is gratefully acknowl-
edged. G.F. thanks MEC for a research grant. Anne-Sophie
Dupain is thanked for help with the preparation of PV devices.
Compound 6. A solution of 5a (100 mg, 0.09 mmol), N-
octylglycine (101 mg, 0.56 mmol), and C60 (541 mg, 0.75 mmol)
in chlorobenzene (50 mL) was heated under reflux overnight. The
solvent was evaporated to dryness, and the crude product was
purified by column chromatography [SiO2, CS2, chloroform] to
1
afford 6 (150 mg, 36%) as a black solid. H NMR (CDCl3, 300
MHz) δ 7.67 (dd, J ) 8.6 Hz, 8H), 7.35-7.20 (m, 8H), 7.08 (s,
2H), 6.95 (s, 2H), 5.38 (br s, 4 H), 5.12 (d, J ) 9.4 Hz, 4H), 4.12
(d, J ) 9.4 Hz, 4H), 4.02-3.98 (br t, J ) 6.4 Hz, 4H), 3.5-3.36
(m, 30 H), 2.72-0.78 (m, 60 H). 13C NMR (CDCl3, 125 MHz) δ
55.7, 153.7, 153.6, 153.5, 153.4, 153.3, 152.7, 152.7, 152.63,
152.60, 147.1, 146.56, 146.50, 146.2, 146.1, 146.0, 145.99, 145.92,
145.8, 145.7, 145.6, 145.58, 145.51, 145.39, 145.31, 145.2, 145.18,
Supporting Information Available: General methods, ad-
ditional Figures S1-4, and copy of 1H and 13C NMR spectra. This
materialisavailablefreeofchargeviatheInternetathttp://pubs.acs.org.
JO702740D
3196 J. Org. Chem., Vol. 73, No. 8, 2008